User experience of home-based AbC-19 SARS-CoV-2 antibody rapid lateral flow immunoassay test
Abstract The urgent need to scale up testing capacity during the COVID-19 pandemic has prompted the rapid development of point-of-care diagnostic tools such as lateral flow immunoassays (LFIA) for large-scale community-based rapid testing. However, studies of how the general public perform when usin...
Main Authors: | Min Jing, Raymond Bond, Louise J. Robertson, Julie Moore, Amanda Kowalczyk, Ruth Price, William Burns, M. Andrew Nesbit, James McLaughlin, Tara Moore |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-05097-y |
Similar Items
-
User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing
by: Min Jing, et al.
Published: (2021-07-01) -
Evaluation of the performance of a lateral flow device for quantitative detection of anti-SARS-CoV-2 IgG
by: J.S. Moore, et al.
Published: (2022-12-01) -
High-Sensitive Detection and Quantitative Analysis of Thyroid-Stimulating Hormone Using Gold-Nanoshell-Based Lateral Flow Immunoassay Device
by: Santosh Kumar Bikkarolla, et al.
Published: (2022-03-01) -
Magnetic Lateral Flow Immunoassays
by: Amanda Moyano, et al.
Published: (2020-05-01) -
A lateral flow immunoassay with self-sufficient microfluidic system for enhanced detection of thyroid-stimulating hormone
by: Santosh Kumar Bikkarolla, et al.
Published: (2020-12-01)